2020
Evaluation of the New American Urological Association Guidelines Risk Classification for Hematuria
Woldu S, Ng C, Loo R, Slezak J, Jacobsen S, Tan W, Kelly J, Lough T, Darling D, van Kessel K, de Jong J, van Criekinge W, Shariat S, Hiar A, Brown S, Boorjian S, Barocas D, Svatek R, Lotan Y. Evaluation of the New American Urological Association Guidelines Risk Classification for Hematuria. Journal Of Urology 2020, 205: 1387-1392. PMID: 33356483, DOI: 10.1097/ju.0000000000001550.Peer-Reviewed Original ResearchConceptsIncidence of bladder cancerBladder cancerHigh-risk groupRisk groupsRisk strataCancer incidenceDegree of hematuriaHigh-risk patientsRisk stratification systemAmerican Urological AssociationEvaluation of patientsMultinational cohort studyRisk-stratified approachBladder cancer incidenceHematuria patientsClinically meaningful categoriesGross hematuriaUrologic evaluationIntermediate riskProspective registryRisk patientsContemporary patientsSmoking historyUrological AssociationHematuria
2017
A Comprehensive Guide to Perioperative Management and Operative Technique for Robotic Cystectomy with Intracorporeal Urinary Diversion
Tan W, Lamb B, Sridhar A, Briggs T, Kelly J. A Comprehensive Guide to Perioperative Management and Operative Technique for Robotic Cystectomy with Intracorporeal Urinary Diversion. Urologia Journal 2017, 84: 71-78. PMID: 28256704, DOI: 10.5301/uj.5000224.Peer-Reviewed Original ResearchMeSH KeywordsCystectomyHumansIleumPerioperative CarePostoperative ComplicationsPractice Guidelines as TopicRobotic Surgical ProceduresUrinary BladderUrinary Bladder NeoplasmsUrinary DiversionConceptsRobotic-assisted radical cystectomyOpen radical cystectomyConversion to open surgeryReturn to normal functionOncological outcomesRadical cystectomyOpen surgeryUrinary diversionEarly return to normal functionLack of level 1 evidenceShort-term oncological outcomesHigh-volume centresLevel 1 evidenceMinimally invasive approachReduce patient morbidityIntracorporeal urinary diversionEnhanced recovery protocolEarly surgical experienceHigh-volume experienceNormal functionRobotic cystectomyOncologic equivalencePerioperative complicationsPatient selectionInvasive approach
2016
Management of non-muscle invasive bladder cancer: A comprehensive analysis of guidelines from the United States, Europe and Asia
Tan W, Rodney S, Lamb B, Feneley M, Kelly J. Management of non-muscle invasive bladder cancer: A comprehensive analysis of guidelines from the United States, Europe and Asia. Cancer Treatment Reviews 2016, 47: 22-31. PMID: 27231966, DOI: 10.1016/j.ctrv.2016.05.002.Peer-Reviewed Original ResearchConceptsNon-muscle invasive bladder cancerBladder cancerAnalysis of guidelinesBladder cancer casesUnited StatesCancer casesInvasive bladder cancerIntravesical treatmentTransurethral resectionExpensive cancerTreatment modalitiesSurveillance protocolsContemporary guidelinesUnited KingdomGuidelinesIntensive treatmentBladderCancerInternational ConsultationTreatmentConsultationUnits